Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry

Early-stage (I and II) ovarian carcinoma patients generally have good prognosis. Yet, some patients die earlier than expected. Thus, it is important to stratify early-stage patients into risk groups to identify those in need of more aggressive treatment regimens. The prognostic value of 29 histotype...

Descripción completa

Detalles Bibliográficos
Autores principales: Engqvist, Hanna, Parris, Toshima Z., Kovács, Anikó, Rönnerman, Elisabeth Werner, Sundfeldt, Karin, Karlsson, Per, Helou, Khalil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040170/
https://www.ncbi.nlm.nih.gov/pubmed/32133296
http://dx.doi.org/10.3389/fonc.2020.00162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040170/
https://www.ncbi.nlm.nih.gov/pubmed/32133296
http://dx.doi.org/10.3389/fonc.2020.00162

Ejemplares similares